Northwest Capital Management Inc Bristol Myers Squibb CO Transaction History
Northwest Capital Management Inc
- $225 Million
- Q4 2024
A detailed history of Northwest Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwest Capital Management Inc holds 400 shares of BMY stock, worth $22,460. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$22,460
Previous $20,000
10.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,671Shares Held
1.47BCall Options Held
31.9MPut Options Held
35.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.39 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.39 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...